Test Price
2,800 AED✅ Home Collection Available
AP1S1 Gene MEDNIK Syndrome Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين AP1S1 لمتلازمة ميدنيك بتقنية التسلسل الجيني المتقدم في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – UAE Patient Trust Guarantee
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Next Generation Sequencing (NGS) processing – every variant confirmed by Sanger validation.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain transport and VIP Mobile Phlebotomy service, available 8 AM–11 PM, 7 days/week.
- Clinical Guidance: Complimentary telephonic post‑test clinical interpretation by a DHA‑licensed genetic counsellor, linked to your referring physician.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731 before collection.
ملخص تنفيذي – ضمان الثقة للمريض في الإمارات
الفحص الجيني لتشخيص متلازمة ميدنيك عبر تحليل جين AP1S1 بدقة تشخيصية تصل إلى 99.9% باستخدام مختبر معتمد من هيئة الصحة بدبي ومطابق للقانون الاتحادي رقم 41 لسنة 2024. الخدمة تشمل سحب العينة منزلياً بتقنية التبريد المعتمدة، والاستشارة الوراثية الهاتفية بعد النتيجة، مع إمكانية التحقق من التغطية التأمينية عبر الواتساب.
Clinical Overview
The AP1S1 gene MEDNIK syndrome NGS test is a high‑resolution Genetic Test is designed for early molecular diagnosis in suspected paediatric and adult patients, enabling targeted management and family counselling. In the UAE, it is processed under DHA‑licensed facility 9834453 with strict adherence to Federal Decree‑Law No. 41 of 2024 and CDS Law 2026 for minors, ensuring all patient data is handled per UAE PDPL.
| Parameter | Our Test (DHA‑Lab 9834453) | Closest Alternative |
|---|---|---|
| Methodology | NGS (Targeted Gene Sequencing) with deletion/duplication analysis | Sanger sequencing (limited to single‑exon; misses large rearrangements) |
| Diagnostic Sensitivity | >99.5% for SNVs & indels; ~95% for CNVs | ~90% for SNVs; cannot detect most CNVs |
| Turnaround Time | 3–4 Weeks (Expedited) | 4–6 Weeks |
| Bioinformatics | ClinVar‑synchronised, ACMG/AMP 2025 classification, reviewed by 3 independent experts | Basic variant calling |
Physician Insight & Safety Protocol
“Genetic testing is a powerful tool, but it cannot replace a comprehensive clinical evaluation. I always advise that any result from the AP1S1 test be interpreted in the context of the patient’s full medical history and family pedigree. As a DHA‑licensed physician, I emphasise that no diagnostic test is 100% definitive; clinical correlation and multi‑disciplinary follow‑up remain essential to ensure the best patient outcome.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011, Senior Clinical Geneticist
⚠ Medication Warning:
Do not discontinue prescribed medication without consulting your doctor. This test does not replace ongoing therapeutic management.
Safety Exclusion Criteria & Red Flags
- Exclusion Criteria: Not intended for asymptomatic individuals without a family history of MEDNIK syndrome; pre‑test genetic counselling is mandatory. Avoid sample collection in neonates with known severe coagulopathy unless cleared by a haematologist.
- Emergency Red Flags After Sample Collection: If you experience excessive bleeding, rapidly expanding haematoma, signs of infection (redness, warmth, pus), or fainting, seek immediate medical attention at the nearest emergency department.
- Vulnerable Groups: Minors must have explicit consent from a legal guardian, fully compliant with UAE CDS Law 2026. All personal health information is protected under UAE PDPL.
Patient FAQ & Clinical Guidance
Q1: What is the AP1S1 MEDNIK syndrome genetic test and who should consider it?
This Genetic Test detects disease‑causing variants in the AP1S1 gene to confirm MEDNIK syndrome in patients with ichthyosis, developmental delay, and hearing loss. Doctors request it for children or adults exhibiting hallmark signs such as keratoderma, enteropathy, and peripheral neuropathy.
س: ما هو فحص جين AP1S1 لمتلازمة ميدنيك ومن الذي يجب أن يفكر فيه؟
ج: فحص التسلسل الجيني المتقدم يكشف الطفرات المرضية في جين AP1S1 المسببة لمتلازمة ميدنيك، ويُنصح به للمرضى الذين يعانون من السماك الجلدي وتأخر النمو وفقدان السمع.
Q2: How accurate is the NGS test and will it give me a definitive answer?
The test achieves over 99.5% analytical sensitivity for single nucleotide variants and small insertions/deletions, and is considered the gold standard for AP1S1 molecular diagnosis. A positive result confirms the syndrome; a negative result reduces suspicion but may require additional testing if symptoms persist.
س: ما مدى دقة فحص التسلسل الجيني وهل سيمنحني إجابة قاطعة؟
ج: تبلغ حساسية الفحص أكثر من 99.5% للطفرات النقطية، مما يجعله المعيار الذهبي لتشخيص متلازمة ميدنيك جزيئياً، مع إمكانية الحاجة لفحوص إضافية في الحالات السلبية النادرة.
Q3: What does the home collection service include and how soon will I get results?
A DHA‑certified phlebotomist arrives at your location between 8 AM and 11 PM, collects a blood or FTA card sample, and transports it in an ISO‑certified cold chain to our genomics lab. The full report is issued within 3 to 4 weeks, and a genetic counsellor explains the findings in a private teleconsultation.
س: ماذا تشمل خدمة السحب المنزلي ومتى تظهر النتائج؟
ج: يحضر أخصائي سحب مرخص من هيئة الصحة إلى منزلك، ويسحب العينة وينقلها بسلسلة تبريد معتمدة، وستصلك النتيجة خلال 3 إلى 4 أسابيع مع استشارة هاتفية من مستشار وراثي.
Pre‑Test Requirements & Specimen Logistics
- Genetic Counselling: A mandatory pre‑ genetic counselling session must be conducted to draw a comprehensive pedigree chart of family members affected by MEDNIK syndrome and to obtain informed consent.
- Sample Type: Whole blood (EDTA tube), extracted DNA, or one drop of blood on an FTA card. For paediatric patients, a buccal swab may be accepted after contacting the lab.
- Drug/Supplement Avoidance: No specific medication interferes with the DNA extraction or sequencing. However, inform the phlebotomist of any anticoagulant therapy for assessment of bleeding risk.
- Cold Chain Commitment: All samples are transported in monitored ISO 9001:2015 compliant containers, maintaining 2–8°C from collection to laboratory.
- Testing Algorithm: NGS with read depth ≥100x, covering all exons ±20 bp intronic boundaries. Any pathogenic or likely pathogenic variant is confirmed by orthogonal Sanger sequencing.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians